Terms: = Bone cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Clinical Outcome
11 results:
1. A novel cxcr4 antagonist counteracts paradoxical generation of cisplatin-induced pro-metastatic niches in lung cancer.
Bertolini G; Cancila V; Milione M; Lo Russo G; Fortunato O; Zaffaroni N; Tortoreto M; Centonze G; Chiodoni C; Facchinetti F; Pollaci G; Taiè G; Giovinazzo F; Moro M; Camisaschi C; De Toma A; D'Alterio C; Pastorino U; Tripodo C; Scala S; Sozzi G; Roz L
Mol Ther; 2021 Oct; 29(10):2963-2978. PubMed ID: 34023505
[TBL] [Abstract] [Full Text] [Related]
2. The
Pansy K; Feichtinger J; Ehall B; Uhl B; Sedej M; Roula D; Pursche B; Wolf A; Zoidl M; Steinbauer E; Gruber V; Greinix HT; Prochazka KT; Thallinger GG; Heinemann A; Beham-Schmid C; Neumeister P; Wrodnigg TM; Fechter K; Deutsch AJ
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554271
[TBL] [Abstract] [Full Text] [Related]
3. CD97 expression is associated with poor overall survival in acute myeloid leukemia.
Vaikari VP; Yang J; Wu S; Alachkar H
Exp Hematol; 2019 Jul; 75():64-73.e4. PubMed ID: 31260716
[TBL] [Abstract] [Full Text] [Related]
4. Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets.
Maiga A; Lemieux S; Pabst C; Lavallée VP; Bouvier M; Sauvageau G; Hébert J
Blood Cancer J; 2016 Jun; 6(6):e431. PubMed ID: 27258612
[TBL] [Abstract] [Full Text] [Related]
5. CXCL12-cxcr4 axis promotes the natural selection of breast cancer cell metastasis.
Sun Y; Mao X; Fan C; Liu C; Guo A; Guan S; Jin Q; Li B; Yao F; Jin F
Tumour Biol; 2014 Aug; 35(8):7765-73. PubMed ID: 24810923
[TBL] [Abstract] [Full Text] [Related]
6. Contemporary drug therapies for multiple myeloma.
de la Puente P; Azab AK
Drugs Today (Barc); 2013 Sep; 49(9):563-73. PubMed ID: 24086952
[TBL] [Abstract] [Full Text] [Related]
7. The molecular and clinicopathologic characteristics of bilateral breast cancer.
Chen SF; Du CW; Yang P; Zhang HW; Kwan M; Zhang GJ
Sci Rep; 2013; 3():2590. PubMed ID: 24005135
[TBL] [Abstract] [Full Text] [Related]
8. The metastatic behavior of osteosarcoma by gene expression and cytogenetic analyses.
Salinas-Souza C; De Oliveira R; Alves MT; Garcia Filho RJ; Petrilli AS; Toledo SR
Hum Pathol; 2013 Oct; 44(10):2188-98. PubMed ID: 23845465
[TBL] [Abstract] [Full Text] [Related]
9. Chemokine receptor cxcr4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival.
Xiang ZL; Zeng ZC; Tang ZY; Fan J; Zhuang PY; Liang Y; Tan YS; He J
BMC Cancer; 2009 Jun; 9():176. PubMed ID: 19508713
[TBL] [Abstract] [Full Text] [Related]
10. Tumor-cell homing to lymph nodes and bone marrow and cxcr4 expression in esophageal cancer.
Kaifi JT; Yekebas EF; Schurr P; Obonyo D; Wachowiak R; Busch P; Heinecke A; Pantel K; Izbicki JR
J Natl Cancer Inst; 2005 Dec; 97(24):1840-7. PubMed ID: 16368946
[TBL] [Abstract] [Full Text] [Related]
11. cxcr4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases.
Russell HV; Hicks J; Okcu MF; Nuchtern JG
J Pediatr Surg; 2004 Oct; 39(10):1506-11. PubMed ID: 15486895
[TBL] [Abstract] [Full Text] [Related]